The Mechatronic Remote Physiotherapy System (MRPS) in Remote Stroke Rehabilitation
- Conditions
- StrokeNeurological Disorder
- Registration Number
- NCT06964789
- Lead Sponsor
- Institute of Technology, Sligo
- Brief Summary
The aim of this pilot trial is to examine and compare the safety and feasibility of enhanced Early Supported Discharge (ESD) through the Mechatronic Remote Physiotherapy System (MRPS) and traditional ESD after stroke.
The main questions this trial aims to answer are:
* Is enhanced ESD via the MRPS safe, feasible and significantly different compared to traditional ESD when administered to patients after stroke?
* Do patients interact with and are they satisfied with the MRPS?
* Is enhanced ESD cost-effective compared to traditional ESD?
* Are there any adverse effects of the MRPS and what are the areas for further improvement?
Participants in the experimental group will receive enhanced ESD through the MRPS.
The intervention will be given for approximately 6-8 weeks in total. Frequency will be determined by how often the participants' use the MRPS themselves. Frequency of use and level of completion of each session will be monitored. Enhanced ESD therapy sessions will be designed to reflect traditional ESD sessions.
Participants in the control group will receive traditional ESD. The intervention will be given for approximately 6-8 weeks in total with a frequency of 1-3 therapy visits per week (as per traditional ESD). Therapy sessions will be designed by therapists delivering the ESD service.
- Detailed Description
The Mechatronic Remote Physiotherapy System (MRPS) is an Online Rehabilitation Platform for neurology patients. The platform has been designed to provide supervised and monitored remote rehabilitation therapy, initially focusing on patients who have suffered a stroke. The system comprises of a patent pending mirror therapy strengthening device, which is a neural therapy device using mirror therapy and exercise apparatus for upper limb rehabilitation. The platform also permits the addition of modules beneficial to the patients' recovery. The use of a sensory substitution balance apparatus and motion capturing sensors are also being developed to allow for lower limb rehabilitation.
Participants will be randomly allocated to an experimental (n=7) or control group (n=7) using a block stratified randomization process. Block randomization will be stratified for age, gender and degree of disability (computer-generated random numbers) with allocation concealment.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 14
- A clinical diagnosis of stroke;
- Completed inpatient rehabilitation;
- A level of ability that would allow them to participate safely (as determined by ESD team);
- Cognitive ability to consent and take part;
- Technological ability and resources to allow them to access MRPS platform;
- A proficiency in the English Language.
- Involvement in other studies or rehabilitation programmes;
- A level of disability that would prevent them from participating safely (as determined by ESD team);
- Low level technological literacy or resources (e.g. Wi-Fi) which would prevent access to MRPS platform;
- Have uncontrolled medical condition or another serious medication condition in addition to stroke;
- Unable to understand or follow directions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Protocol Adherence/Compliance Rate. through study completion, an average of 1 year Percentage of scheduled procedures, visits, or assessments completed as planned. 95% adherence/compliance rate suggest strong adherence/compliance rate.
- Secondary Outcome Measures
Name Time Method Berg Balance Scale (BBS). through study completion, an average of 1 year Outcome measure to assess static and dynamic balance with high validity and reliability within the stroke population. The Berg Balance Scale (BBS) is a clinical tool used to assess a person's balance through a series of 14 functional tasks, each scored on a scale from 0 to 4, with a maximum total score of 56. An increase in total BBS score from baseline indicates improved balance. A change of 6-7 points is often considered the minimal detectable change (MDC) in older adults or people with balance issues (i.e., change likely reflects a real improvement, not measurement error).
Fugl Meyer Assessment (FMA). through study completion, an average of 1 year Stroke-specific, performance-based impairment index outcome measure. The Fugl-Meyer Assessment (FMA) is a widely used, validated tool to evaluate motor function, balance, sensation, and joint performance in individuals after a stroke. It is particularly focused on motor recovery and is considered one of the most comprehensive quantitative measures of physical impairment post-stroke. The full Fugl-Meyer Assessment includes 5 domains, with a total possible score of 226 points. Higher scores indicate better motor recovery/function. Change in score over time reflects improvement or decline.
In stroke rehabilitation:10-point increase in motor score is typically considered clinically meaningful. Smaller changes (e.g., 5-7 points) may still be relevant depending on the baseline and context.